DNA and RNA Synthesizer Market Trends: the global market size is projected to reach USD 0.38 billion by 2031

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "DNA and RNA Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global DNA and RNA Synthesizer market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for DNA and RNA Synthesizer was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 381 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5515035/dna-and-rna-synthesizer



DNA & RNA Synthesizer Market: Strategic Forecast & Analysis (2026-2032)

1. Technology & Market Overview
A DNA and RNA synthesizer is a sophisticated laboratory instrument that builds custom oligonucleotide sequences from individual nucleotide building blocks. Functioning as a precision "printer" for genetic code, it is foundational to modern biotechnology. Demand is fueled by the rapid expansion of synthetic biology, mRNA therapeutics, CRISPR gene editing, and next-generation diagnostics. The market is characterized by a dual-track evolution: high-throughput, GMP-compliant industrial systems for pharmaceutical production and flexible, modular benchtop units for academic and research laboratories.

2. Market Size & Growth Forecast
The global DNA and RNA synthesizer market is on a stable growth path, projected to reach USD 0.38 billion by 2031, advancing at a Compound Annual Growth Rate (CAGR) of 3.9%. This steady expansion reflects the instrument's transition from a niche research tool to an essential piece of infrastructure in the burgeoning bioeconomy.

3. Competitive Landscape & Manufacturing Hubs
The market features a mix of specialized innovators and established life science leaders.

In 2024, the top nine players held a significant combined market share, indicating a concentrated competitive environment.

Key manufacturers driving the market include Kilobaser, Polygen GmbH, Biolytic Lab Performance, K&A Labs GmbH, BIOSSET Ltd., CSBio, Cytiva, LGC Biosearch Technologies, and Hunan Honya Biotech Co., Ltd.

Manufacturing is concentrated in North America and Western Europe, benefiting from mature supply chains and strong R&D ecosystems. East Asia is emerging as a significant growth region for production and assembly, leveraging its advanced precision manufacturing and growing domestic biopharma sector.

4. Industry Chain Analysis

Upstream: The supply chain is reliant on high-purity, specialized inputs: nucleotide precursors, coupling reagents, microfluidic chips, precision fluidic components, and optical detection modules. Intellectual property around synthesis chemistry and system design is a critical barrier to entry.

Midstream: Core activities encompass the design, assembly, and support of synthesizers. This includes developing tiered systems (from benchtop to industrial), offering customization for specific applications (e.g., long-read or modified synthesis), and providing comprehensive post-sales maintenance, software updates, and training.

Downstream: End-users are segmented by distinct needs:

Academic & Research Institutions: Require flexibility, user-friendly operation, and cost-effectiveness for diverse, small-batch projects in basic research, synthetic biology, and genomics.

Pharmaceutical & Biotechnology Companies: Demand large-scale, GMP-compliant production with exceptional purity, batch consistency, and full data traceability for nucleic acid drug R&D (mRNA, siRNA, gene therapy) and diagnostic assay manufacturing.

5. Key Market Drivers & Policy Impact
Growth is propelled by the therapeutic and diagnostic revolution in nucleic acids. Supportive yet stringent regulatory frameworks are shaping equipment requirements:

US FDA Guidance (2024): Mandates validated process controls and data integrity features for synthesizers used in GMP production, pushing innovation in pharmaceutical-grade systems.

EU IVDR (2022): Classifies synthesizers for diagnostic oligonucleotide production as ancillary equipment, increasing demands for validation and traceability documentation.

China NMPA Guidelines (2023): Set specific technical standards for mRNA vaccine production equipment, creating opportunities for domestic manufacturers with localized GMP-compliant models.

6. Critical Industry Trends

Shift to Enzymatic Synthesis: Moving from traditional chemical methods to enzyme-based systems for longer, higher-fidelity DNA/RNA sequences, reducing errors and post-synthesis purification costs.

Integration of AI & Automation: Machine learning is being embedded to optimize sequence design, enable ultra-high-throughput library synthesis, and facilitate real-time error correction, drastically accelerating R&D timelines.

End-to-End GMP Systems: Development of integrated industrial platforms that combine synthesis, purification, and quality control with built-in GMP data management for streamlined pharmaceutical manufacturing.

Modular Benchtop Innovation: Growing demand for versatile, space-efficient systems that can switch between synthesis of standard primers, modified oligonucleotides, and small-batch libraries, catering to diverse lab needs.

7. Strategic Market Opportunities

Academic Access Models: Offering cost-effective, modular benchtop systems paired with shared core-facility licensing to overcome budget constraints in research institutions.

Pharma Co-Development Partnerships: Collaborating with large biopharma firms to co-engineer next-generation, GMP-compliant synthesizers for commercial-scale production of advanced therapeutics.

AI-Driven Synthesis Services: Providing on-demand, high-throughput oligonucleotide library synthesis as a service to biotech startups, eliminating their need for major capital investment.

Validated Therapeutic Toolkits: Developing pre-validated hardware and software modules specifically for synthesizing regulated, modified oligonucleotides (e.g., for ASO drugs), reducing clients' regulatory burden.

8. Primary Challenges to Growth

Technical Hurdles in Long-Sequence Synthesis: Achieving high-yield, high-purity synthesis of very long oligonucleotides and those with complex modifications remains a significant R&D challenge.

High Cost Barriers: The substantial upfront cost of advanced and GMP-compliant systems limits access for academic labs and small-to-midsize enterprises, potentially stifling innovation.

Regulatory Complexity: Navigating and complying with diverse global regulatory standards requires massive investment, creating a market advantage for large, established players.

Fragile Supply Chains: Dependence on a limited number of suppliers for critical high-purity reagents and specialized components creates vulnerability to disruptions, impacting production timelines across the industry.



The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The DNA and RNA Synthesizer market is segmented as below:
By Company
Kilobaser
Polygen GmbH
Biolytic Lab Performance
K&A Labs GmbH
BIOSSET Ltd.
CSBio
Cytiva
LGC Biosearch Technologies
Hunan Honya Biotech Co., Ltd.

Segment by Type
Laboratory Grade
Industrial Grade
Large-scale Synthesis Grade

Segment by Application
Academic Institution
Pharmaceutical Company
Others

Each chapter of the report provides detailed information for readers to further understand the DNA and RNA Synthesizer market:

Chapter 1: Introduces the report scope of the DNA and RNA Synthesizer report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of DNA and RNA Synthesizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various DNA and RNA Synthesizer market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of DNA and RNA Synthesizer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of DNA and RNA Synthesizer in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth DNA and RNA Synthesizer competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides DNA and RNA Synthesizer comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides DNA and RNA Synthesizer market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global DNA and RNA Synthesizer Market Outlook, InDepth Analysis & Forecast to 2031
Global DNA and RNA Synthesizer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global DNA and RNA Synthesizer Market Research Report 2025
DNA and RNA Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global DNA and RNA Synthesizers Market Outlook, InDepth Analysis & Forecast to 2031
Global DNA and RNA Synthesizers Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
DNA and RNA Synthesizers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global DNA and RNA Synthesizers Market Research Report 2025
Global Automated DNA and RNA Synthesizer Market Outlook, InDepth Analysis & Forecast to 2031
Automated DNA and RNA Synthesizer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Automated DNA and RNA Synthesizer Market Research Report 2025
Global Automated DNA and RNA Synthesizer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.